Sexually transmitted infection with an immune-escape mutant hepatitis B virus in an hepatitis B virus-vaccinated individual with acute HIV-hepatitis C virus infection.
Patrick
P
Ingiliz
Ingiliz
I
Patrick
Ivanka
I
Krznaric
Krznaric
K
Ivanka
Martin
M
Obermeier
Obermeier
O
Martin
D000208:Acute Disease; D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D018791:CD4 Lymphocyte Count; D000069454:Darunavir; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004359:Drug Therapy, Combination; D000068679:Emtricitabine; D006679:HIV Seropositivity / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D006509:Hepatitis B / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D017325:Hepatitis B Vaccines / Q000008:administration & dosage*; D006515:Hepatitis B virus / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification; D006526:Hepatitis C / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D018451:Homosexuality, Male; D006801:Humans; D008297:Male; D063065:Organophosphonates / Q000008:administration & dosage*; D013449:Sulfonamides / Q000008:administration & dosage*; D000068698:Tenofovir; D016896:Treatment Outcome; D047568:Unsafe Sex; D019562:Viral Load
D019380:Anti-HIV Agents; D017325:Hepatitis B Vaccines; D063065:Organophosphonates; D013449:Sulfonamides; D003841:Deoxycytidine; D000068698:Tenofovir; D000068679:Emtricitabine; D000225:Adenine; D000069454:Darunavir